LCG
MDT icon

Lynx Capital Group’s Medtronic MDT Stock Holding History

Lynx Capital Group’s Portfolio MDT Stock Details MDT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-34,407
Closed -$2.98M – 93
2026
Q1 		$2.98M Sell
34,407
-161
-0.5% -$15.4K 1.39% 37
2025
Q4 		$3.32M Sell
34,568
-82
-0.2% -$7.96K 1.52% 29
2025
Q3 		$3.3M Buy
34,650
+103
+0.3% +$9.47K 1.53% 29
2025
Q2 		$3.01M Sell
34,547
-24
-0.1% -$2.04K 1.45% 28
2025
Q1 		$3.11M Buy
34,571
+6,312
+22% +$565K 1.6% 25
2024
Q4 		$2.26M Sell
28,259
-79
-0.3% -$6.84K 1.3% 40
2024
Q3 		$2.55M Buy
28,338
+175
+0.6% +$14.7K 1.65% 33
2024
Q2 		$2.22M Buy
28,163
+56
+0.2% +$4.59K 1.53% 32
2024
Q1 		$2.45M Buy
28,107
+1,157
+4% +$98.7K 1.65% 28
2023
Q4 		$2.22M Buy
+26,950
New +$2.05M 1.62% 31

Other funds holding MDT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Lynx Capital Group's MDT Position: Q2 2026 in Review

Lynx Capital Group sold out of Medtronic (MDT) in Q2 2026, closing a stake of 34,407 shares — an estimated $2.98M sold.

Lynx Capital Group first reported a position in MDT in Q4 2023 and held it in 10 quarters. The position peaked at $3.32M in Q4 2025. 2,044 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • Lynx Capital Group reported no remaining Medtronic position as of Q2 2026 after selling out during the quarter.
  • Lynx Capital Group sold 34,407 Medtronic shares in Q2 2026, an estimated $2.98M.
  • Lynx Capital Group first reported a position in Medtronic in Q4 2023 and held it in 10 quarters.
  • Lynx Capital Group's Medtronic position peaked at $3.32M in Q4 2025.
  • 2,044 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on Lynx Capital Group's 13F filing for Q2 2026, filed 12 Aug 2026.